Subtractive Cloning and Characterization of DRAL, a Novel LIM-Domain Protein Down-Regulated in Rhabdomyosarcoma
The DOI matches its Crossref record.
Abstract
A subtractive cloning procedure was used to characterize the molecular changes involved in transformation of normal myoblasts to rhabdomyosarcoma (RMS) cells. Here we describe the cloning of DRAL, a novel LIM-domain protein expressed in primary myoblasts but down-regulated in the RMS cell line RD. DRAL is a LIM-only protein with five LIM domains whereby one LIM domain consists only of the second half of the consensus motif. Interestingly, down-regulation of DRAL was not confined to the RD RMS cells, but was a phenomenon extended to other RMS cell lines of both embryonal and alveolar subtype, and to some breast cancer cell lines. Analysis of the expression pattern in normal human tissues revealed that DRAL is expressed at high levels in the heart, suggesting an important function in the specification of the terminally differentiated phenotype of heart muscle cells. Immunofluorescence studies using an antibody directed against recombinant DRAL localized the protein predominantly in the nucleus of cultured cells. On the basis of these results, we conclude that down-regulation of DRAL correlates with the tumor phenotype of RMS cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
LIM domains: multiple roles as adapters and functional modifiers in protein interactions
Dawid, I. B., Breen, J. J., & Toyama, R. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01424-3 · Cited by 600
Suppression of FOXO1 activity by FHL2 through SIRT1‐mediated deacetylation
Yang, Y., Hou, H., Haller, E. M., Nicosia, S. V., & Bai, W. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600570 · Cited by 348
FHL2, a novel tissue-specific coactivator of the androgen receptor
Muller, J. M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.359 · Cited by 326
Signaling routes to CREM and CREB: plasticity in transcriptional activation
De Cesare, D., Fimia, G. M., & Sassone-Corsi, P. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01414-0 · Cited by 312
Overview of the Muscle Cytoskeleton
Henderson, C. A., Gomez, C. G., Novak, S. M., Mi‐Mi, L., & Gregorio, C. C. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c160033 · Cited by 278
Metadata
- Authors
- GENINI, M., SCHWALBE, P., SCHOLL, F. A., REMPPIS, A., MATTEI, M.-G., & SCHÄFER, B. W.
- Venue
- DNA and Cell Biology
- Publisher
- SAGE Publications
- Published
- 1997-04
- Volume
- 16
- Issue
- 4
- Pages
- 433-442
- ISSN
- 1044-5498 (ISSN-L)
- 1557-7430
- OpenAlex
- W2087938232
- Cited by
- 123
- References
- 0
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Subtractive Cloning and Characterization of DRAL, a Novel LIM-Domain Protein Down-Regulated in Rhabdomyosarcoma. https://app.cochat.ai/papers/10.1089/dna.1997.16.433
- The paper
- GENINI, M., SCHWALBE, P., SCHOLL, F. A., REMPPIS, A., MATTEI, M.-G., & SCHÄFER, B. W. (1997). Subtractive Cloning and Characterization of DRAL, a Novel LIM-Domain Protein Down-Regulated in Rhabdomyosarcoma. DNA and Cell Biology. https://doi.org/10.1089/dna.1997.16.433
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.